MedQAIR
FDA 510(k) Regulatory Consulting Firm
MedQAIR is a consulting firm specializing in FDA 510(k) regulatory consulting for international medical device manufacturers. Their services include 510(k) submissions for Class I and Class II general hospital devices, helping clients achieve successful market clearances.
About
MedQAIR is a consulting firm specializing in FDA 510(k) regulatory consulting for international medical device manufacturers. Their services include 510(k) submissions for Class I and Class II general hospital devices, helping clients achieve successful market clearances.
Additional information
### **Additional information**
- **Type:** firm
- **Company:** MedQAIR
- **Years of experience:** 12
- **510(k)s submitted (self-reported):** 10
- **Regions served:** US, EU
- **Client types:** large_medtech
- **Location:** United States
- **Availability:** available_now
### **Cruxi analysis**
- **Strength summary:** MedQAIR, a consulting firm with 12 years of dedicated experience, offers a highly specialized focus on FDA 510(k) regulatory consulting. Their unique value lies in expertly guiding international medical device manufacturers, particularly those in the EU, through the US FDA 510(k) pathway. They possess specific expertise in traditional 510(k) submissions for Class I and Class II general hospital devices, providing a targeted and efficient approach to achieving successful market clearances for clients seeking entry into the US.
- **Unique value:** MedQAIR's key differentiator is its highly specialized focus on FDA 510(k) submissions for international manufacturers of Class I and Class II general hospital devices, offering a streamlined and expert pathway to US market clearance.
- **Ideal projects:** The ideal client for MedQAIR is an international medical device manufacturer, especially those based in the EU, developing Class I or Class II general hospital devices. These clients are specifically seeking to navigate the US FDA 510(k) regulatory pathway for market access and require comprehensive support for traditional 510(k) submissions. Projects best suited for MedQAIR involve a clear scope for 510(k) clearance, aligning well with their fixed-project pricing structure, and benefit from their focused expertise rather than broader regulatory needs.
- **Confidence score:** 70/100
- **Last analyzed:** Sun Dec 14 2025 01:14:53 GMT-0500 (Eastern Standard Time)
### **Qualifications & scope**
- **Submission types:** 510k-traditional
- **Device classes:** class-i, class-ii
- **Specialties:** general-hospital
- **Type:** firm
- **Company:** MedQAIR
- **Years of experience:** 12
- **510(k)s submitted (self-reported):** 10
- **Regions served:** US, EU
- **Client types:** large_medtech
- **Location:** United States
- **Availability:** available_now
### **Cruxi analysis**
- **Strength summary:** MedQAIR, a consulting firm with 12 years of dedicated experience, offers a highly specialized focus on FDA 510(k) regulatory consulting. Their unique value lies in expertly guiding international medical device manufacturers, particularly those in the EU, through the US FDA 510(k) pathway. They possess specific expertise in traditional 510(k) submissions for Class I and Class II general hospital devices, providing a targeted and efficient approach to achieving successful market clearances for clients seeking entry into the US.
- **Unique value:** MedQAIR's key differentiator is its highly specialized focus on FDA 510(k) submissions for international manufacturers of Class I and Class II general hospital devices, offering a streamlined and expert pathway to US market clearance.
- **Ideal projects:** The ideal client for MedQAIR is an international medical device manufacturer, especially those based in the EU, developing Class I or Class II general hospital devices. These clients are specifically seeking to navigate the US FDA 510(k) regulatory pathway for market access and require comprehensive support for traditional 510(k) submissions. Projects best suited for MedQAIR involve a clear scope for 510(k) clearance, aligning well with their fixed-project pricing structure, and benefit from their focused expertise rather than broader regulatory needs.
- **Confidence score:** 70/100
- **Last analyzed:** Sun Dec 14 2025 01:14:53 GMT-0500 (Eastern Standard Time)
### **Qualifications & scope**
- **Submission types:** 510k-traditional
- **Device classes:** class-i, class-ii
- **Specialties:** general-hospital
Key Highlights
- MedQAIR, a consulting firm with 12 years of dedicated experience, offers a highly specialized focus on FDA 510(k) regulatory consulting. Their unique value lies in expertly guiding international medical device manufacturers, particularly those in the EU, through the US FDA 510(k) pathway. They possess specific expertise in traditional 510(k) submissions for Class I and Class II general hospital devices, providing a targeted and efficient approach to achieving successful market clearances for cli
- MedQAIR's key differentiator is its highly specialized focus on FDA 510(k) submissions for international manufacturers of Class I and Class II general hospital devices, offering a streamlined and expert pathway to US market clearance.
Certifications & Trust Signals
- 12 years experience
- 10 510(k)s submitted (self-reported)
Buyer Snapshot
Best for
- The ideal client for MedQAIR is an international medical device manufacturer, especially those based in the EU, developing Class I or Class II general hospital devices. These clients are specifically seeking to navigate the US FDA 510(k) regulatory pathway for market access and require comprehensive support for traditional 510(k) submissions. Projects best suited for MedQAIR involve a clear scope
HQ:
United States
Languages:
English
Status:
listed
Services & Capabilities
FDA 510(k) Submission Services
Jurisdictions:
US
Services Offered:
Regulatory Pathway Assessment
Pathways Supported:
Traditional 510(k)
Device Types Supported:
Medical device
Years Experience:
12
Num510k Submitted:
10
Ex FDA:
No
Ex Notified Body:
No
Ex Big Medtech:
No
Engagement Models:
fixed_fee
Accepting New Clients:
No
